Characterization of HLA-DR- and TCR-binding residues of an immunodominant and genetically permissive peptide of the 16-kDa protein of Mycobacterium tuberculosis

European Journal of Immunology

Volumn 34, Issue 8, 2004, Pages 2220-2229

  Caccamo, Nadia ^a   Meraviglia, Serena ^a   La Mendola, Carmela ^a   Bosze, Szylvia ^b   Hudecz, Ferencz ^b   Ivanyi, Juraj ^c   Dieli, Francesco ^a   Salerno, Alfredo ^a,d  

^a UNIVERSITY OF PALERMO   (Italy)

^b EÖTVÖS LORÁND UNIVERSITY   (Hungary)

^c KING'S COLLEGE LONDON   (United Kingdom)

^d CNR   (Italy)

Author keywords

16 kDa M. tuberculosis antigen; Binding; CD4+ T cells; HLA DR; TCR

Indexed keywords

BACTERIAL PROTEIN; BACTERIAL VACCINE; EPITOPE; HLA ANTIGEN; HLA DR ANTIGEN; HLA DR1 ANTIGEN; HLA DR11 ANTIGEN; HLA DR13 ANTIGEN; HLA DR15 ANTIGEN; HLA DR7 ANTIGEN; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG; LYMPHOCYTE ANTIGEN RECEPTOR; PEPTIDE;

ALLELE; AMINO TERMINAL SEQUENCE; ARTICLE; BCG VACCINATION; CELL CLONING; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG DESIGN; DRUG PROTEIN BINDING; HUMAN; HUMAN CELL; IMMUNOGENETICS; LATENT PERIOD; MOLECULAR RECOGNITION; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; SEQUENCE ANALYSIS; IMMUNOLOGY; T LYMPHOCYTE;

BACTERIAL PROTEINS; HLA-DR ANTIGENS; HUMANS; MYCOBACTERIUM TUBERCULOSIS; PEPTIDES; RECEPTORS, ANTIGEN, T-CELL; T-LYMPHOCYTES;

EID: 4444271804     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200425090     Document Type: Article

References (37)

1. Dye, C., Scheele, S., Dolin, P., Pathania, V. and Raviglione M. C., Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence and mortality by country. WHO Global Surveillance and Monitoring Project. JAMA 1999. 282: 677-686.
2. Fine, P. E., Variation in protection by BCG: implications of and for heterologous immunity. Lancet 1995. 346: 1339-1345.
3. Flynn, J. L. and Chan, J., Immunology of tuberculosis. Annu. Rev. Immunol. 2001. 19: 93-129.
4. Agrewala, J. N. and Wilkinson, R. J., Differential regulation of Th1 and Th2 cells by p91-110 and p21-40 peptides of the 16-kDa α-crystallin antigen of Mycobacterium tuberculosis. Clin. Exp. Immunol. 1998. 114: 392-397.
5. Dieli, F., Singh, M., Spallek, R., Romano, A., Titone, L., Sireci, G., Fruscia, G., Di Sano, C., Santini, D., Salerno, A. and Ivanyi, J., Change of Th0 to Th1 cell-cytokine profile following tuberculosis chemotherapy. Scand. J. Immunol. 2000. 52: 96-102.
6. Dieli, F., Friscia, G., Di Sano, C., Ivanyi, J., Singh, M., Spallek, R., Sireci, G., Titone, L. and Salerno, A., Sequestration of T lymphocytes to body fluids in tuberculosis: reversal of anergy following chemotherapy. J. Infect. Dis. 1999. 180: 225-228.
7. Friscia, G., Vordermeier, H. M., Pasvol, G., Harris, D. P., Moreno, C. and Ivanyi, J., Human T cell responses to peptide epitopes of the 16-kDa antigen in tuberculosis. Clin. Exp. Immunol. 1995. 102: 53-57.
8. + T clones specific for an immunodominant epitope of Mycobacterium tuberculosis 16-kDa protein. Clin. Exp. Immunol. 2003. 133: 260-266.
9. Jurcevic, S., Hills, A., Pasvol, G., Davidson, R. N., Ivanyi, J. and Wilkinson, R. J., T cell response to a mixture of Mycobacterium tuberculosis peptides with complementary HLA-DR binding profile. Clin. Exp. Immunol. 1996. 105: 416-421.
10. Vordermeier, H. M., Harris, D. P., Moreno, C. and Ivanyi, J., Promiscuous T cell recognition of an H-2 IA-presented mycobacterial epitope. Eur. J. Immunol. 1994. 24: 2061-2067.
11. Corper, A. L., Stratmann, T., Apostolopoulos, V., Scott, C. A., Garcia, K. C., Kang, A. S., Wilson, I. A. and Teyton, L., A structural framework for deciphering the link between I-Ag7 and autoimmune diabetes. Science 2000. 288: 505-511.
12. Fremont, D. H., Hendrickson, W. A., Marrack, P. and Kappler, J., Structures of an MHC class II molecule with covalently bound single peptides. Science 1996. 272: 1001-1004.
13. Brown, J. H., Jardetzky, T. S., Gorga, J. C., Stern, L. J., Urban, R. G., Strominger, J. L. and Wiley, D. C., Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1. Nature 1993. 364: 33-39.
14. Latek, R. R., Suri, A., Petzold, S. J., Nelson, C. A., Kanagawa, O., Unanue, E. R. and Fremont, D. H., Structural basis of peptide binding and presentation by the type I diabetes-associated MHC class II molecule of NOD mice. Immunity 2000. 12: 699-710.
15. Smith, K. J., Pyrdol, J., Gauthier, L., Wiley, D. C. and Wucherpfennig, K. W., Crystal structure of HLA-DR2 (DRA*0101, DRB1*1501) complexed with a peptide from human myelin basic protein. J. Exp. Med. 1998. 188: 1511-1520.
16. Scott, C. A., Peterson, P. A., Teyton, L. and Wilson, I. A., Crystal structures of two I-Ad-peptide complexes reveal that high affinity can be achieved without large anchor residues. Immunity 1998. 8: 319-329.
17. Fremont, D. H., Monnaire, D., Nelson, C. A., Hendrickson, W. A. and Unanue, E. R., Crystal structure of I-Ak in complex with a dominant epitope of lysozyme. Immunity 1998. 8: 305-317.
18. Stern, L. J., Brown, J. H., Jardetzky, T. S., Gorga, J. C., Urban, R. G., Strominger, J. L. and Wiley, D. C., Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide. Nature 1994. 368: 215-221.
19. Ghosh, P., Amaya, M., Mellins, E. and Wiley, D. C., The structure of an intermediate in class II MHC maturation: CLIP bound to HLA-DR3. Nature 1995. 378: 457-462.
20. Dessen, A., Lawrence, C. M., Cupo, S., Zaller, D. M. and Wiley, D. C., X-ray crystal structure of HLA-DR4 (DRA*0101, DRB*10401) complexed with a peptide from human collagen II. Immunity 1997. 7: 473-481.
21. Li, Y., Li, H., Martin, R. and Mariuzza, R. A., Structural basis for the binding of an immunodominant peptide from myelin basic protein in different registers by two HLA-DR2 proteins. J. Mol. Biol. 2000. 304: 177-188.
22. Lee, K. H., Wucherpfennig, K. W. and Wiley D. C., Structure of a human insulin peptide-HLA-DQ8 complex and susceptibility to type 1 diabetes. Nat. Immunol. 2001. 2: 501-507.
23. Hennecke, J., Carfi, A. and Wiley, D. C., Structure of a covalently stabilized complex of a human T cell receptor, influenza HA peptide and MHC class II molecule, HLA-DR1. EMBO J. 2000. 19: 5611-5624.
24. Reinherz, E. L., Tan, K., Tang, L., Kern, P., Liu, J., Xiong, Y., Hussey, R. E., Smolyar, A., Hare, B., Zhang, R., Joachimiak, A., Chang, H. C., Wagner, G. and Wang, J., The crystal structure of a T cell receptor in complex with peptide and MHC class II. Science 1999. 286: 1913-1921.
25. Liu, X., Dai, S., Crawford, F., Fruge, R., Marrack, P. and Kappler, J., Alternate interactions define the binding of peptides to the MHC molecule IA(b). Proc. Natl. Acad. Sci. USA 2002. 99: 8820-8825.
26. + T cells that are dependent on MHC class II-bound peptide-flanking residues. J. Immunol. 2002. 169: 739-749.
27. Vignali, D. A. A., Urban, R. G., Chiez, R. M. and Strominger, J. L., Minute quantities of a single immunodominant epitope are presented as large nested sets by MHC class II molecules. Eur. J. Immunol. 1993. 23: 1602-1607.
28. k. Proc. Natl. Acad. Sci. USA 1992. 89: 7380-7383.
29. Shi Y., Kaliyaperumal, A., Lu, L., Southwood, S., Sette, A., Michaels, M. A. and Datta, S. K., Promiscuous presentation and recognition of nucleosomal autoepitopes in lupus: role of autoimmune T cell receptor alpha chain. J. Exp. Med. 1998. 187: 367-378.
30. Garboczi, D. N., Ghosh, P., Utz, U., Fan, Q. R., Biddison, W. E. and Wiley, D. C., Structure of the complex between human T cell receptor, viral peptide and HLA-A2. Nature 1996. 384: 134-141.
31. Garcia, K. C., Degano, M., Stanfield, R. L., Brunmark, A., Jackson, M. R., Peterson, P. A., Teyton, L. and Wilson, I. A., An alpha-beta T cell receptor structure at 2.5 A and its orientation in the TCR-MHC complex. Science 1996. 274: 209-219.
32. Jorgensen, J. L., Esser, U., Reay, P. A., Fazekas de St. Groth, B. and Davis, M. M., Mapping T cell receptor/peptide contacts by variant peptide immunization of single-chain transgenics. Nature 1992. 355: 224-230.
33. Nanda, N. K., Arzoo, K. K, Geyser, H. M., Sette, A. and Sercarz, E. E., Recognition of multiple peptide cores by a single T cell receptor. J. Exp. Med. 1995. 182: 531-539.
34. Sant'Angelo, D. B., Waterbury, G., Preston-Hulbert, P., Yoon, S. T., Medzhitov, R., Hong, S. C., Janeway, C. A., The specificity and orientation of a TCR to its peptide-MHC class II ligands. Immunity 1996. 4: 367-376.
35. Sun, R., Shepherd, S. E., Geier, S. S., Thomson, C. T., Sheil, J. M., Nathenson, S. G., Evidence that the antigen receptors of cytotoxic T lymphocytes interact with a common recognition pattern on the H-2Kb molecule. Immunity 1995. 3: 573-582.
36. Petersen, T. R., Bettelli, E., Sidney, J., Sette, A., Kuchro, V. and Backstrom, B. T., Characterization of MHC- and TCR-binding residues of the myelin oligodrendrocyte glycoprotein 38-51 peptide. Eur. J. Immunol. 2004. 34: 165-173.
37. Saulquin, X., Ibisch, C., Peyrat, M. A., Scotet, E., Hourmant, M., Vie, H., Bonneville, M. and Houssaint, E., A global appraisal of immunodominant CD8 T cell responses to Epstein-Barr virus and cytomegalovirus by bulk screening. Eur. J. Immunol. 2000. 30: 2531-2539.